Exact Mass: 426.1066
Exact Mass Matches: 426.1066
Found 62 metabolites which its exact mass value is equals to given mass value 426.1066
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
(3-(2-(4-(2-(Trifluoromethyl)phenoxy)piperidin-1-yl)thiazol-5-yl)-1,2,4-oxadiazol-5-yl)methanol
Lenvatinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents
8-Deoxy-15-(3-hydroxy-2-methyl-propanoyl)-lactucin-3-sulfate
9alpha,11-dihydroxy-13-chloro-11,13-dihydroatripliciolide-8-O-angelate
(5E,8Z,14Z)-6-iodoicosa-5,8,14,19-tetraen-11-ynoic acid
5-O-beta-D-glucopyranosyl-1,3,8-trihydroxy-5,6,7,8-tetrahydroxanthone
19-Ac-(ent-4beta,7alpha,12betaH)-18-Chloro-15,16-epoxy-4,7,19-trihyrdroxy-3,6-dioxo-13(16),14-clerodadien-20,12-olide
Ala Cys Cys Met
Ala Cys Met Cys
Ala Met Cys Cys
Cys Ala Cys Met
Cys Ala Met Cys
Cys Cys Ala Met
Cys Cys Cys Val
Cys Cys Met Ala
Cys Cys Val Cys
Cys Met Ala Cys
Cys Met Cys Ala
Cys Val Cys Cys
Met Ala Cys Cys
Met Cys Ala Cys
Met Cys Cys Ala
Val Cys Cys Cys
(3-ETHOXYCARBONYL-2-OXOPROPLY)TRIPHENYLPHOSPHONIUM CHLORIDE
5-(2-Fluoro-3-methoxyphenyl)-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methyl-2,4(1H,3H)-pyrimidinedione
.beta.-D-Glucopyranosiduronic acid, phenyl 1-thio-, methyl ester, triacetate
ICI 199,441 hydrochloride
ICI 199441 is a potent and selective κ-opioid receptor agonist. ICI 199441 can improve heart resistance to ischemia/reperfusion[1].
2-amino-4-(3-chlorophenyl)-6-(2-furanylmethyl)-7-methyl-5-oxo-4H-pyrano[3,2-c]pyridine-3-carboxylic acid methyl ester
2-[[3-(3,4-dimethoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]thio]-N-(5-methyl-3-isoxazolyl)acetamide
1-[3-({[(4-Amino-5-fluoro-2-methylquinolin-3-YL)methyl]thio}methyl)phenyl]-2,2,2-trifluoroethane-1,1-diol
(4AR,6R,7S,8R,8AR)-8-((5R,6R)-3-Carboxy-tetrahydro-4,5,6-trihydroxy-2H-pyran-2-yloxy)-hexahydro-6,7-dihydroxy-2-methylpyrano[3,2-D][1,3]dioxine-2-carboxylic acid)
Lenvatinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents